- Antimicrobial profile of Gram-negative bacterial isolates (continuation).
| Antibiotics | Morganella morganii n=(4) | Enterobacter cloacae n=(6) | Proteus mirabilis n=(3) | Providencia sp. n=(1) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | R | S | T | R | S | T | R | S | T | R | S | |
| Meropenem | - | - | - | 1 | 1 (100) | 0 (0) | - | - | - | - | - | - |
| Amikacin | 1 | 0 (0) | 1 (100) | 1 | 1 (100) | 0 (0) | - | - | - | 1 | 0 (0) | 1 (100) |
| Ciprofloxacin | 4 | 3 (75.0) | 1 (25.0) | 6 | 2 (33.3) | 4 (66.7) | 2 | 1 (50.0) | 1 (50.0) | 1 | 1 (100) | 0 (0) |
| Gentamicin | 4 | 0 (0) | 4 (100) | 6 | 1 (16.7) | 5 (83.3) | 2 | 0 (0) | 2 (100) | 1 | 1 (100) | 0 (0) |
| Imipenem | - | - | - | 1 | 1 (100) | 0 (0) | - | - | - | - | - | - |
| Trimethoprim-sulfamethoxazole | 4 | 2 (50.0) | 2 (50.0) | 6 | 2 (33.3) | 4 (66.7) | 2 | 1 (50.0) | 1 (50.0) | 1 | 1 (100) | 0 (0) |
| Ertapenem | 1 | 0 (0) | 1 (100) | 3 | 1 (33.3) | 2 (66.7) | - | - | - | 1 | 0 (0) | 1 (100) |
| Cefepime | 4 | 0 (0) | 4 (100) | 5 | 0 (0) | 5 (100) | - | - | - | 1 | 0(0) | 1 (100) |
| Piperacillin tazobactam | - | - | - | - | - | - | 1 | 0 (0) | 1 (100) | - | - | - |
| Amoxicillin/clavulanic acid | - | - | - | - | - | - | 1 | 0 (0) | 1 (100) | - | - | - |
| Cefazoline | - | - | - | - | - | - | 1 | 0 (0) | 1 (100) | - | - | - |
| Tigecycline | - | - | - | - | - | - | - | - | - | - | - | - |
| Ceftazidime | - | - | - | - | - | - | - | - | - | - | - | - |
| Cefuroxime | - | - | - | - | - | - | - | - | - | - | - | - |
Data reported as number and percentage (%). T: total number of isolates tested against each antibiotic, R: number of isolates resistance to antibiotic, S: number of isolates sensitive to antibiotic, – represents ‘not done’, sp.: species